Aspen Aerogels, Inc. (NYSE:ASPN) Receives $18.44 Average Price Target from Analysts

Shares of Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eleven analysts that are covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $18.44.

Several equities research analysts have weighed in on ASPN shares. Barclays restated an "equal weight" rating and set a $7.00 target price (down from $13.00) on shares of Aspen Aerogels in a research note on Thursday, May 29th. Oppenheimer downgraded Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research report on Thursday, May 8th.

Aspen Aerogels Price Performance

Shares of ASPN traded down $0.26 during trading hours on Monday, hitting $6.58. 1,393,720 shares of the company were exchanged, compared to its average volume of 1,916,254. The company has a quick ratio of 3.53, a current ratio of 4.22 and a debt-to-equity ratio of 0.40. Aspen Aerogels has a fifty-two week low of $4.16 and a fifty-two week high of $33.15. The company has a market cap of $539.87 million, a price-to-earnings ratio of -1.88 and a beta of 2.65. The firm's fifty day moving average is $6.07 and its 200 day moving average is $7.73.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Aspen Aerogels had a negative net margin of 65.47% and a positive return on equity of 6.69%. The firm had revenue of $78.72 million for the quarter, compared to the consensus estimate of $82.75 million. During the same period in the prior year, the company posted ($0.02) earnings per share. The business's revenue for the quarter was down 16.7% on a year-over-year basis. On average, equities analysts anticipate that Aspen Aerogels will post 0.17 earnings per share for the current fiscal year.

Insider Buying and Selling at Aspen Aerogels

In other Aspen Aerogels news, CEO Donald R. Young acquired 20,000 shares of the company's stock in a transaction that occurred on Monday, May 12th. The stock was acquired at an average price of $5.35 per share, for a total transaction of $107,000.00. Following the acquisition, the chief executive officer directly owned 550,856 shares in the company, valued at $2,947,079.60. This represents a 3.77% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 3.40% of the company's stock.

Hedge Funds Weigh In On Aspen Aerogels

Several large investors have recently modified their holdings of the business. Invesco Ltd. increased its position in shares of Aspen Aerogels by 3.5% during the fourth quarter. Invesco Ltd. now owns 50,871 shares of the construction company's stock worth $604,000 after buying an additional 1,724 shares during the period. Alps Advisors Inc. raised its position in shares of Aspen Aerogels by 1.7% in the 1st quarter. Alps Advisors Inc. now owns 126,326 shares of the construction company's stock worth $807,000 after acquiring an additional 2,093 shares in the last quarter. MetLife Investment Management LLC lifted its stake in shares of Aspen Aerogels by 6.3% in the 4th quarter. MetLife Investment Management LLC now owns 35,782 shares of the construction company's stock valued at $425,000 after purchasing an additional 2,118 shares during the period. Swiss National Bank boosted its position in shares of Aspen Aerogels by 1.9% during the 4th quarter. Swiss National Bank now owns 128,800 shares of the construction company's stock valued at $1,530,000 after purchasing an additional 2,400 shares in the last quarter. Finally, Journey Strategic Wealth LLC increased its holdings in Aspen Aerogels by 17.3% in the first quarter. Journey Strategic Wealth LLC now owns 17,596 shares of the construction company's stock worth $112,000 after purchasing an additional 2,596 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.